- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07696442
Sleep, Music, And Research Trial 2.0 (SMART-2)
Music-Based Intervention for Pediatric Epilepsy
The goal of this clinical trial is to learn if a music-based intervention works to improve sleep and health in children with epilepsy and their parents. It will also learn about the feasibility and acceptability of the music-based intervention.
The main questions it aims to answer are:
- Does the music-based intervention improve sleep and health for both the children and their parents?
- How frequently and for how long do participants listen to the music?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Researchers will compare two different music modules, an experimental module and a control module, to determine if the experimental module yields better outcomes.
Participants will:
- Listen to one of the two assigned music modules twice a day (once before bedtime and once after waking up) for 6 months.
- Complete 4 assessments, include wearing an activity and sleep tracking device, keeping a daily sleep diary, and filling out questionnaires.
- Maintain a diary to record any seizure activity.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Shao-Yu Tsai, PhD
- Phone Number: 288904 +886223123456
- Email: stsai@ntu.edu.tw
Study Locations
-
-
Taiwan
-
Taipei, Taiwan, Taiwan, 100
- National Taiwan University Hospital
-
Contact:
- Shao-Yu Tsai, PhD
- Phone Number: 288904 +886223123456
- Email: stsai@ntu.edu.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children aged between 1.5 and 9 years with epilepsy;
- Parents with sufficient Chinese language proficiency and skills to comprehend the study procedures and complete questionnaires.
Exclusion Criteria:
- Children who have severe hearing loss even with the use of hearing devices;
- Children who are bedridden;
- Children with a documented sleep disorder, such as obstructive or central sleep apnea and sleep-related movement disorders;
- Children with severe motor dysfunction that preclude differentiation of sleep and wake states via actigraphy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental intervention group
Participants will listen to the experimental music module twice daily (before bedtime and upon waking) for 6 months.
|
Participants will listen to a standardized nighttime music piece within approximately 30 minutes before their habitual bedtime and a daytime intervention music piece upon waking each day for 6 months.
|
|
Placebo Comparator: Active control group
Participants will listen to the control music module twice daily (before bedtime and upon waking) for 6 months.
|
Participants will listen to a standardized nighttime music piece within approximately 30 minutes before their habitual bedtime and a daytime placebo music piece upon waking each day for 6 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep Efficiency
Time Frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
|
Sleep efficiency, measured objectively using actigraphy, is a key indicator of sleep quality.
It is calculated as the ratio of total nighttime sleep time to time in bed, multiplied by 100%.
|
Baseline, 2 weeks, 3 months, and 6 months after randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Nighttime Sleep
Time Frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
|
Total Nighttime Sleep is defined as the total duration (minutes) scored as sleep within the nocturnal rest interval.
|
Baseline, 2 weeks, 3 months, and 6 months after randomization
|
|
Daily 24-hour Sleep Duration
Time Frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
|
Daily 24-hour sleep duration is defined as total nighttime sleep plus nap duration.
|
Baseline, 2 weeks, 3 months, and 6 months after randomization
|
|
Sleep Onset Latency
Time Frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
|
Sleep onset latency is defined as the duration (minutes) from diary-reported bedtime to actigraphy-derived sleep onset.
|
Baseline, 2 weeks, 3 months, and 6 months after randomization
|
|
Wake After Sleep Onset
Time Frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
|
Wake after sleep onset (WASO) is defined as the duration (minutes) scored as wake between sleep onset and final awakening.
|
Baseline, 2 weeks, 3 months, and 6 months after randomization
|
|
Children's Sleep Habits Questionnaire (CSHQ)
Time Frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
|
The CSHQ is a 45-item parent-reported questionnaire used to assess sleep behaviors in children.
Higher scores indicate more sleep problems.
|
Baseline, 2 weeks, 3 months, and 6 months after randomization
|
|
Child Behavior Checklist (CBCL)
Time Frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
|
CBCL is a parent-report instrument that evaluates behavioral and emotional problems in children.
|
Baseline, 2 weeks, 3 months, and 6 months after randomization
|
|
Pittsburgh Sleep Quality Index
Time Frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
|
The Pittsburgh Sleep Quality Index (PSQI) is used to assess the overall sleep quality of parents, with higher scores indicating greater sleep disturbances.
|
Baseline, 2 weeks, 3 months, and 6 months after randomization
|
|
Center for Epidemiologic Studies Depression Scale
Time Frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
|
The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item questionnaire used to measure parents' symptoms of depression, with higher scores indicating more persistent symptoms.
|
Baseline, 2 weeks, 3 months, and 6 months after randomization
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202601052RINC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
University of California, San FranciscoAttune Neurosciences IncRecruitingEpilepsy | Epilepsy, Generalized | Epilepsy, Drug Resistant | Drug-Resistant Epilepsy | Epilepsy, Focal | Epilepsy (Treatment Refractory) | Epilepsy ComorbiditiesUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
University Hospital, LilleCompletedFocal Epilepsy | Epilepsy IntractableFrance
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustNot yet recruitingEpilepsy Intractable | Epilepsy in Children
Clinical Trials on Music-based intervention
-
Universidade da MadeiraRecruitingHealth People | Survivors of StrokePortugal
-
Northern Arizona UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingChronic Pain | Stress | Generalized Anxiety | Depression DisorderUnited States
-
Sharon Wang-PriceTexas Woman's UniversityRecruitingChronic Low Back PainUnited States
-
Northeastern UniversityRecruitingAlzheimer DiseaseUnited States
-
Brigham and Women's HospitalCompleted
-
University of MinnesotaNational Center for Complementary and Integrative Health (NCCIH)TerminatedPain | Preterm BirthUnited States
-
Region SkaneUnknownStress | Sleep | Personality | Cognition - Other | Complete Psychological Check UpSweden
-
Athens General Children's Hospital "Pan. & Aglaia...Oslo Metropolitan UniversityCompleted
-
Toronto Rehabilitation InstituteUniversity of Toronto; Ontario Centres of ExcellenceCompletedMyocardial Infarction | Patient Compliance | Compliance BehaviorCanada
-
The First Affiliated Hospital with Nanjing Medical...CompletedBreast Cancer | Chemotherapy-Related Cognitive ImpairmentChina